glp-1 87 kg journey History of glucagon-like peptide-1 receptor agonists GLP-1 receptor agonism: a transformative

This type of fat is often linked with hormonal change, insulin resistance, reduced muscle mass, stress and lower activity levels

Ambulatory blood pressure monitoring offers superior assessment compared to isolated office measurements

Without resistance training, up to 40% of weight loss can come from muscle mass

Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5

PubMed Objective: Although the pathogenesis of non-alcoholic fatty liver disease (NAFLD) has been extensively studied, the role of its underlying pathogenesis remains unclear, and there is currently no approved therapeutic strategy for NAFLD